Genentech has crossed over into the unbelievable with the pricing plan it has instituted for its new therapy for breast and lung cancer, $100,000 a year.
Latest Tweets
-
RT @modernbioethics: Rapid DNA sequencing may soon be routine part of each patient's medical record: Rapid DNA sequencing may soon be... t.co/Qh4gBWv8 Time ago 18 Hours
- Trained Interpreters Can Help Prevent Medical Errors t.co/wn9gzrAr #bioethics Time ago 24 Hours
- RT @amednews: University of Michigan Health Care System’s apology program has saved $2 million a year in litigation costs t.co/c0ljewty Time ago 24 Hours
- Waiting for Health Care Documentary t.co/MZiBVG2Z #bioethics Time ago 2 Days
- Children (Conceived with Frozen Sperm) Not Entitled to Dead Father’s Benefits, Justices Rule t.co/3EtnXi5O #bioethics Time ago 2 Days
Follow @bioethics_net on twitter.
-